Revolutionising Surgery Scheduling: an innovative AI-powered health-tech platform enhancing Operating Room efficiency, with an automated schedule unlocking the potential for an additional 10% or 350K surgeries annually in the UK.

彻底改变%20手术%20调度：%20an%20创新%20AI驱动%20健康科技%20平台%20增强%20操作%20房间%20效率，%20与%20an%20自动化%20调度%20解锁%20%20潜力%20用于%20an%20额外%

• 批准号: 10095646
• 金额: $ 25.99万
• 依托单位: OPALFLOW LTD
• 依托单位国家: 英国
• 项目类别: Collaborative R&D
• 财政年份: 2024
• 资助国家: 英国
• 起止时间: 2024 至 无数据
• 项目状态: 未结题
• 来源: https://gtr.ukri.org/projects?ref=10095646
• 关键词: Revolutionising; Surgery; Scheduling; innovative; AI

OpalFlow is a UK-based digital health SME with a core project team of Natalie Cooke CEO (Registered Nurse/MSc International Healthcare Management) and Radovan Vitek CTO (full-stack developer/MSc Software Engineering).The UK's extensive waiting list for elective surgeries, which exceeds 7 million people, particularly impacts patients awaiting hip and knee replacements and cancer treatments. These individuals experience deteriorating conditions that have a negative impact on their mental and physical well-being. For cancer patients, even a four-week delay in receiving surgery increases the risk of mortality by 6-8%. Additionally, the underutilisation of Operating Rooms (ORs) results in a missed opportunity for approximately 350,000 surgeries annually, further prolonging waiting lists and undermining public confidence in the system.OpalFlow aims to address these challenges by developing a comprehensive AI-based web and mobile app for OR scheduling. The platform automates all aspects of managing OR capacity with the potential to increase the number of surgeries by up to 10%.The project's primary focus will be on patients waiting for hip and knee replacements, especially those experiencing severe chronic pain. The Midlands, with the longest waiting list for hip and knee replacements in the UK (<150,000 people), will benefit significantly from OpalFlow's efforts to increase the number of surgeries in this region.This initiative aligns directly with the NHS Delivery plan, addressing the backlog of elective care resulting from the COVID-19 pandemic. The plan outlines clear goals for the recovery of elective services over the next three years, making OpalFlow's project opportune and valuable in supporting the plan's objectives.

OpalFlow是一家总部位于英国的数字健康中小企业，其核心项目团队由Natalie Cooke CEO(注册护士/MSc国际医疗保健管理)和Radovan Vitek CTO(全栈开发人员/MSc软件工程)组成。英国广泛的选择性手术等待名单超过700万人，特别是对等待髋关节和膝盖置换以及癌症治疗的患者的影响。这些人的病情不断恶化，对他们的身心健康产生了负面影响。对于癌症患者来说，即使延迟四周接受手术，死亡的风险也会增加6-8%。此外，手术室(OR)的未充分利用导致每年约350,000例手术错失机会，进一步延长了等待名单，并破坏了公众对系统的信心。OpalFlow旨在通过开发一款全面的基于人工智能的网络和移动应用程序来应对这些挑战，用于手术室调度。该平台自动化了OR能力管理的所有方面，有可能将手术数量增加高达10%。该项目的主要重点将是等待髋关节和膝关节置换的患者，特别是那些经历严重慢性疼痛的患者。米德兰兹郡拥有英国最长的髋关节和膝关节置换等待名单(150,000人)，将从OpalFlow增加该地区手术数量的努力中受益匪浅。这一倡议直接与英国国民健康保险制度的交付计划保持一致，解决了因新冠肺炎疫情而积压的选择性护理。该计划概述了未来三年恢复选修服务的明确目标，使OpalFlow的项目成为支持该计划目标的有利时机和有价值的项目。